LACTB expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.307400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.622200E-02
Normal-vs-Stage2
4.167200E-01
Normal-vs-Stage3
3.934200E-01
Normal-vs-Stage4
7.803800E-01
Stage1-vs-Stage2
1.492960E-01
Stage1-vs-Stage3
4.776800E-01
Stage1-vs-Stage4
9.476200E-02
Stage2-vs-Stage3
5.999000E-01
Stage2-vs-Stage4
6.331200E-01
Stage3-vs-Stage4
4.793400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.163400E-01
Normal-vs-AfricanAmerican
3.526000E-01
Normal-vs-Asian
3.689000E-01
Caucasian-vs-AfricanAmerican
6.432000E-01
Caucasian-vs-Asian
6.845800E-01
AfricanAmerican-vs-Asian
9.122000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.776800E-01
Normal-vs-Female
4.137400E-01
Male-vs-Female
3.260800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.791000E-01
Normal-vs-Age(41-60Yrs)
5.241600E-01
Normal-vs-Age(61-80Yrs)
2.633800E-01
Normal-vs-Age(81-100Yrs)
3.343800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.986600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.787800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.176800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.500300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.670000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.185600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.440000E-01
Normal-vs-Daily Drinker
2.710600E-01
Normal-vs-Weekly Drinker
4.319400E-01
Normal-vs-Occasional Drinker
2.000600E-01
Normal-vs-Social Drinker
3.161800E-01
Non Drinker-vs-Daily Drinker
7.018400E-01
Non Drinker-vs-Weekly Drinker
7.868800E-01
Non Drinker-vs-Occasional Drinker
8.164800E-01
Non Drinker-vs-Social Drinker
5.728000E-01
Daily Drinker-vs-Weekly Drinker
6.118200E-01
Daily Drinker-vs-Occasional Drinker
8.834200E-01
Daily Drinker-vs-Social Drinker
4.273800E-01
Weekly Drinker-vs-Occasional Drinker
6.719800E-01
Weekly Drinker-vs-Social Drinker
8.498800E-01
Occasional Drinker-vs-Social Drinker
4.421800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.293400E-01
Normal-vs-Grade 2
6.459800E-01
Normal-vs-Grade 3
2.163600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.381090E-03
Grade 1-vs-Grade 3
7.836000E-03
Grade 1-vs-Grade 4
7.293400E-01
Grade 2-vs-Grade 3
8.936800E-01
Grade 2-vs-Grade 4
6.459800E-01
Grade 3-vs-Grade 4
2.163600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.464400E-01
Normal-vs-NonDiabetic
2.936400E-01
Diabetic-vs-NonDiabetic
6.041800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.048000E-01
Normal-vs-NoPancreatitis
3.155600E-01
Pancreatitis-vs-NoPancreatitis
8.837800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.497450E-01
Normal-vs-N1
4.682400E-01
N0-vs-N1
2.744400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.098800E-01
Normal-vs-TP53-NonMutant
1.994170E-01
TP53-Mutant-vs-TP53-NonMutant
5.054200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
